Clinical Trial Update: Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

View source ↗

Summary

A completed post-marketing surveillance trial evaluating long-term safety of the pioglitazone/metformin hydrochloride combination tablets in adults with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone/metformin hydrochloride combination tablets (pioglitazone/metformin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2016-11-22